CXCL12 and acute lymphoblastic leukemia: Moreover, Activin A was demonstrated to significantly enhance in vitro the migration of B-ALL cells in response to CXCL12, even if present at very low doses, while inhibiting the migration of healthy CD34+ cells [63].